← back to search

Rakez Kayed

The University of Texas at Austin · US
Area of research
Physiology · Neurology
Research interest
Research interests include Alzheimer's disease research and treatments, Neuroinflammation and Neurodegeneration Mechanisms, Parkinson's Disease Mechanisms and Treatments, and Prion Diseases and Protein Misfolding.
h-index
75
citations
35,988
works
324
NIH funding
primary concept
email

Recent publications

Retinal ganglion cell vulnerability to pathogenic tau in Alzheimer’s disease
Acta Neuropathologica Communications 2025cited by 18position: middledoi
Particulate matter and co-occurring genetic risk induce oxidative stress and cardiac and brain Alzheimer’s pathology
Communications Biology 2025cited by 4position: middledoi
Untwisted α-Synuclein Filaments Formed in the Presence of Lipid Vesicles
Biochemistry 2022cited by 16position: middledoi
Amyloid Oligomers: A Joint Experimental/Computational Perspective on Alzheimer’s Disease, Parkinson’s Disease, Type II Diabetes, and Amyotrophic Lateral Sclerosis
Chemical Reviews 2021cited by 657position: middledoi
Tau induces formation of α-synuclein filaments with distinct molecular conformations
Biochemical and Biophysical Research Communications 2021cited by 35position: middledoi
Distinct cryo-EM Structure of α-synuclein Filaments derived by Tau
bioRxiv (Cold Spring Harbor Laboratory) 2021cited by 8position: middledoi
Untwisted α-synuclein Filaments formed in the Presence of Lipid Vesicles
bioRxiv (Cold Spring Harbor Laboratory) 2021cited by 0position: middledoi
Alzheimer’s disease brain-derived extracellular vesicles spread tau pathology in interneurons
Brain 2020cited by 271position: middledoi
Revisiting the intersection of amyloid, pathologically modified tau and iron in Alzheimer’s disease from a ferroptosis perspective
Progress in Neurobiology 2019cited by 143position: middledoi
iPSC-Derived Human Microglia-like Cells to Study Neurological Diseases
Neuron 2017cited by 1,160position: middledoi
Cerebral Microvascular Accumulation of Tau Oligomers in Alzheimer’s Disease and Related Tauopathies
Aging and Disease 2017cited by 122position: lastdoi
Tau oligomers in cerebrospinal fluid in Alzheimer's disease
Annals of Clinical and Translational Neurology 2017cited by 74position: lastdoi
A native interactor scaffolds and stabilizes toxic ATAXIN-1 oligomers in SCA1
eLife 2015cited by 45position: middledoi
Ataxin-1 oligomers induce local spread of pathology and decreasing them by passive immunization slows Spinocerebellar ataxia type 1 phenotypes
eLife 2015cited by 23position: middledoi
Small Misfolded Tau Species Are Internalized via Bulk Endocytosis and Anterogradely and Retrogradely Transported in Neurons
Journal of Biological Chemistry 2012cited by 545position: middledoi
Identification of oligomers at early stages of tau aggregation in Alzheimer's disease
The FASEB Journal 2012cited by 522position: lastdoi
Differential Activation of the ER Stress Factor XBP1 by Oligomeric Assemblies
Neurochemical Research 2012cited by 47position: middledoi
Vaccination with a non-human random sequence amyloid oligomer mimic results in improved cognitive function and reduced plaque deposition and micro hemorrhage in Tg2576 mice
Molecular Neurodegeneration 2012cited by 38position: middledoi

Grants

No grants ingested yet.

Frequent collaborators

Urmi Sengupta · The University of Texas Medical Branch at Galveston8 papers (2012–2022)Mario J. Borgnia · Center for Cancer Research4 papers (2021–2022) · 4 papers (2021–2022)Lucas Dillard · North Carolina State University4 papers (2021–2022) · 4 papers (2021–2022)Kenneth A. Taylor · Florida State University4 papers (2021–2022)Diana L. Castillo‐Carranza · University of Monterrey4 papers (2012–2017)Alimohammad Hojjatian · Virginia Commonwealth University4 papers (2021–2022)Cristian A. Lasagna‐Reeves · Baylor College of Medicine3 papers (2012–2015)Marcos J. Guerrero-Muñoz · The University of Texas Medical Branch at Galveston3 papers (2012–2015)Huda Y. Zoghbi · Howard Hughes Medical Institute2 papers (2015–2015)Dianne W. Taylor · Florida State University2 papers (2021–2021)Juan C. Troncoso · Johns Hopkins Hospital2 papers (2012–2017)Ronald Richman · Baylor College of Medicine2 papers (2015–2015)Jessica Wu · University of Alabama at Birmingham2 papers (2012–2012)Maxime W.C. Rousseaux · University of Ottawa2 papers (2015–2015)Fatemeh Abbasi Yeganeh · Florida State University2 papers (2021–2021)Paymaan Jafar‐Nejad · Ionis Pharmaceuticals (United States)2 papers (2015–2015)Nadia Daneshparvar · Florida State University2 papers (2021–2021)Brian Michael · Massachusetts Institute of Technology2 papers (2021–2021)